Safilo Group SpA ADR(SAFLY)
USD --+0.00%
Reward52Moderate
Risk50Moderate
📊75%Data
Thin 5% profit margin
SAFLY
+0.0 · +0.00%
USD · PINK
Safilo Group SpA ADR | Healthcare
Balanced
Market Cap:839.60M
ℹ️
Reward Rating
52
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
50
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on SAFLY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Safilo Group SpA ADR?

engages in the design, manufacture, and distribution of optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally.

SAFLY · Verdict

Moderate reward · moderate risk

SAFLY's standout is profitability; volatility and growth weigh on the picture.

Based on 88% data coverage

SAFLY · Verdict

What’s working & what to watch

Strengths 1

  • Profitability65/100

    2% net margin · 11% ROE

Watchouts 2

  • Volatility35/100

    Below average

  • Growth44/100

    Rev +0.8% CAGR · earnings +1.6%

Model-based scoring. For information only — not financial advice.

What is Safilo Group SpA ADR?

engages in the design, manufacture, and distribution of optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally. The company offers its products under the own brands, including Carrera, Polaroid Eyewear, Seventh Street, Smith, Blenders Eyewear, and Privé Revaux Eyewear; and licensed brands, such as BOSS, Carolina Herrera, DSQUARED2, Etro, Fossil, HUGO, Isabel Marant, David Beckham, Juicy Couture, Kate Spade New York, Levi's, Liz Claiborne, Love Moschino, Marc Jacobs, Missoni, Moschino, Pierre Cardin, PORTS, Stuart Weitzman, Tommy Hilfiger, TOMMY JEANS, and Under Armour. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 839.60M, and a P/E ratio of 15.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (52)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap839.60M
P/E Ratio15.3846
Dividend YieldN/A
52 Week High4
52 Week Low2.23
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding196M
No. of Employees3,449
IndustryMedical Instruments & Supplies
ExchangePINK
Beta1.309
CurrencyUSD · Reports in EUR